4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2018 / Systematic review
A systematic review evaluated 113 controlled human intervention trials testing 17 putative superfoods on risk markers for metabolic syndrome. Studied foods included garlic (21 trials), flaxseed (22 trials), cocoa (16 trials), blueberries (8 trials), and strawberries (7 trials). The authors found limited overall evidence for beneficial impacts on waist circumference, BMI, blood pressure, blood glucose, or lipids, citing inconsistent findings across trials and a small number of studies for many evaluated foods.
van den Driessche JJ, Plat J, Mensink RP Food Funct, 2018. PMID 29557436
2013 / Prospective longitudinal cohort studies (pooled analysis)
Researchers analyzed 187,382 US health professionals across three prospective cohorts over 3,464,641 person-years of follow-up, identifying 12,198 incident cases of type 2 diabetes. Every three servings/week of total whole fruit consumption was associated with a pooled hazard ratio (HR) of 0.98 (95% CI 0.97 to 0.99) for type 2 diabetes. Risk differed significantly among individual fruits (P<0.001); pooled HRs per three servings/week were 0.74 (0.66 to 0.83) for blueberries, 0.88 (0.83 to 0.93) for grapes and raisins, and 0.93 (0.90 to 0.96) for apples and pears, while fruit juice was associated with an increased risk (pooled HR 1.08, 1.05 to 1.11).
Shows an association, not proof of cause and effect.
Muraki I, Imamura F, Manson JE, et al. BMJ, 2013. PMID 23990623
2019 / Pilot study
A pilot study evaluated the postprandial effects of high-fat/high-glycemic load meals enriched with blueberries in 5 obese/overweight patients with metabolic syndrome. Significant decreases in urinary methylamines, acetoacetate, acetone, and succinate were observed at 2 and 4 hours post-ingestion, alongside accumulation of gut-derived phenolic acids. In mononuclear blood cells, mRNA expression of interleukin-6 significantly decreased and transforming growth factor-β significantly increased following blueberry supplementation.
Sobolev AP, Ciampa A, Ingallina C, et al. Metabolites, 2019. PMID 31295937
2017 / Randomized controlled trial
Adults with metabolic syndrome were randomized to consume either freeze-dried blueberry smoothies or a placebo twice daily for six weeks. Blueberry supplementation reduced superoxide and total reactive oxygen species in monocytes and whole blood compared to placebo (p ≤ 0.05). It also raised myeloid dendritic cell counts, decreased monocyte expression of TNF-alpha, IL-6, and TLR4, and decreased circulating GMCSF levels (p ≤ 0.05).
Nair AR, Mariappan N, Stull AJ, et al. Food Funct, 2017. PMID 29019365
2017 / Randomized crossover trial
Forty healthy older adults aged 50 to 70 consumed a mixed berry beverage or a matched control beverage daily for five weeks in a randomized crossover trial. The berry drink reduced total and LDL cholesterol compared to baseline (P < 0.05) and compared to control (P < 0.005 and P < 0.01). Working memory performance improved after the berry beverage compared to control (P < 0.05), but other cardiometabolic variables remained unchanged.
Nilsson A, Salo I, Plaza M, et al. PLoS One, 2017. PMID 29141041
2010 / Randomized controlled trial
A double-blind, randomized, placebo-controlled study evaluated twice-daily smoothies with 22.5 g blueberry bioactives or placebo for 6 weeks in 32 obese, insulin-resistant adults. Mean insulin sensitivity improved more with blueberries (1.7 ± 0.5 mg·kg FFM⁻¹·min⁻¹) than with placebo (0.4 ± 0.4 mg·kg FFM⁻¹·min⁻¹, P = 0.04). Adiposity, energy intake, and inflammatory biomarkers did not change significantly.
Stull AJ, Cash KC, Johnson WD, et al. J Nutr, 2010. PMID 20724487
2012 / Prospective cohort study
Researchers tracked 200,894 US men and women across three cohorts for up to 24 years, documenting 12,611 incident cases of type 2 diabetes across 3,645,585 person-years of follow-up. Higher anthocyanin intake was significantly linked to a lower diabetes risk (pooled HR comparing extreme quintiles: 0.85; 95% CI: 0.80, 0.91; P-trend < 0.001) after multivariate adjustment. Consuming anthocyanin-rich foods was also linked to lower risk, specifically blueberries (pooled HR for ≥2 servings/wk vs <1 serving/mo: 0.77; 95% CI: 0.68, 0.87; P-trend < 0.001) and apples/pears (pooled HR for ≥5 servings/wk vs <1 serving/mo: 0.77; 95% CI: 0.65, 0.83; P-trend < 0.001). Total flavonoid intake and other subclasses showed no significant associations.
Shows an association, not proof of cause and effect.
Wedick NM, Pan A, Cassidy A, et al. Am J Clin Nutr, 2012. PMID 22357723